KLC
ANGO icon

Kent Lake Capital’s AngioDynamics ANGO Stock Holding History

Kent Lake Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$4.54M Buy
+750,000
New +$4.63M 2.05% 24

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kent Lake Capital's ANGO Position: Q2 2024 in Review

Kent Lake Capital opened a new position in AngioDynamics (ANGO) in Q2 2024: 750,000 shares worth $4.54M. The stake represents 2.05% of the portfolio and ranks #24 among its holdings.

140 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Kent Lake Capital held 750,000 shares of AngioDynamics worth $4.54M as of Q2 2024.
  • AngioDynamics was a new Kent Lake Capital position in Q2 2024.
  • AngioDynamics made up 2.05% of Kent Lake Capital's portfolio in Q2 2024, its #24 holding.
  • 140 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Kent Lake Capital's 13F filing for Q2 2024, filed 14 Aug 2024.